• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体疗法治疗耐药性铜绿假单胞菌尿路感染。

Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection.

机构信息

Centre for Infectious Diseases and Microbiology, Sydney West Area Health Service, NSW 2145, Australia.

Special Phage Services Pty, Brookvale, Sydney, NSW, Australia.

出版信息

J Med Microbiol. 2011 Nov;60(Pt 11):1697-1700. doi: 10.1099/jmm.0.029744-0. Epub 2011 Jul 7.

DOI:10.1099/jmm.0.029744-0
PMID:21737541
Abstract

We describe the success of adjunctive bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection in the context of bilateral ureteric stents and bladder ulceration, after repeated failure of antibiotics alone. No bacteriophage-resistant bacteria arose, and the kinetics of bacteriophage and bacteria in urine suggest self-sustaining and self-limiting infection.

摘要

我们描述了在双侧输尿管支架和膀胱溃疡的情况下,辅助噬菌体治疗难治性铜绿假单胞菌尿路感染的成功案例,此前单独使用抗生素治疗已反复失败。没有出现噬菌体耐药菌,噬菌体和尿液中的细菌动力学表明感染具有自我维持和自我限制的特征。

相似文献

1
Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection.噬菌体疗法治疗耐药性铜绿假单胞菌尿路感染。
J Med Microbiol. 2011 Nov;60(Pt 11):1697-1700. doi: 10.1099/jmm.0.029744-0. Epub 2011 Jul 7.
2
Macrophage inflammatory protein-2, neutrophil recruitment and bacterial persistence in an experimental mouse model of urinary tract infection.巨噬细胞炎性蛋白-2、中性粒细胞募集与尿路感染实验小鼠模型中的细菌持续存在
Microbes Infect. 2004 Nov;6(14):1326-32. doi: 10.1016/j.micinf.2004.08.008.
3
Urinary-tract escherichia coli with cross-reactive antigens to encapsulated pyogenic bacteria.具有与包膜化脓性细菌交叉反应抗原的泌尿道大肠杆菌。
Lancet. 1972 Aug 5;2(7771):250-3. doi: 10.1016/s0140-6736(72)91687-x.
4
[Clinical study of Pseudomonas aeruginosa isolated from the urine of patients with urinary tract infections].[从尿路感染患者尿液中分离出的铜绿假单胞菌的临床研究]
Hinyokika Kiyo. 1992 Jan;38(1):37-41.
5
Investigations on the efficacy of specific immunization with corpuscular vaccines in urinary tract infections with Pseudomonas aeruginosa or mixed bacteria.关于用微粒疫苗进行特异性免疫接种对铜绿假单胞菌或混合细菌引起的尿路感染的疗效研究。
Arch Roum Pathol Exp Microbiol. 1984 Jan-Mar;43(1):39-52.
6
Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa.噬菌体治疗增强补体介导的细菌溶解作用,并在多重耐药铜绿假单胞菌引起的急性肺部感染后增强细菌清除。
J Infect Dis. 2019 Apr 16;219(9):1439-1447. doi: 10.1093/infdis/jiy678.
7
Genotypic identification of Pseudomonas aeruginosa strains isolated from patients with urinary tract infection.从尿路感染患者中分离的铜绿假单胞菌菌株的基因分型鉴定。
Comp Immunol Microbiol Infect Dis. 2019 Aug;65:23-28. doi: 10.1016/j.cimid.2019.03.014. Epub 2019 Apr 2.
8
The Prevalence of pilA and algD Virulence Genes in Pseudomonas aeruginosa Urinary Tract and Tracheal Isolates.铜绿假单胞菌尿道和气管分离株中pilA和algD毒力基因的流行情况
Infect Disord Drug Targets. 2017;17(2):86-89. doi: 10.2174/1871526517666170427121956.
9
Bacteremia complicating urinary tract infection by Pseudomonas aeruginosa: Mortality risk factors.铜绿假单胞菌引起的泌尿道感染合并菌血症:死亡风险因素。
Int J Urol. 2019 Mar;26(3):358-362. doi: 10.1111/iju.13872. Epub 2018 Dec 21.
10
Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).某单一机构中由铜绿假单胞菌引起的复杂性尿路感染(1999 - 2003年)
Int J Urol. 2006 May;13(5):538-42. doi: 10.1111/j.1442-2042.2006.01359.x.

引用本文的文献

1
Bacteriophages as an alternative strategy for the treatment of drug resistant bacterial infections: Current approaches and future perspectives.噬菌体作为治疗耐药细菌感染的替代策略:当前方法与未来展望。
Cell Surf. 2025 Jul 3;14:100149. doi: 10.1016/j.tcsw.2025.100149. eCollection 2025 Dec.
2
[Potential of bacteriophage therapy in Germany: evidence and clinical relevance].[德国噬菌体疗法的潜力:证据与临床相关性]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 Apr 28. doi: 10.1007/s00103-025-04048-y.
3
Antibiotic-Resistant : Current Challenges and Emerging Alternative Therapies.
抗生素耐药性:当前挑战与新兴替代疗法
Microorganisms. 2025 Apr 16;13(4):913. doi: 10.3390/microorganisms13040913.
4
Emerging antimicrobial therapies for Gram-negative infections in human clinical use.目前正在临床应用的针对革兰氏阴性菌感染的新型抗菌疗法。
NPJ Antimicrob Resist. 2025 Feb 27;3(1):16. doi: 10.1038/s44259-025-00087-2.
5
The rise, fall, and resurgence of phage therapy for urinary tract infection.用于治疗尿路感染的噬菌体疗法的兴衰与复兴
EcoSal Plus. 2024 Dec 12;12(1):eesp00292023. doi: 10.1128/ecosalplus.esp-0029-2023. Epub 2024 Jan 11.
6
The Potential of Phage Treatment to Inactivate Planktonic and Biofilm-Forming .噬菌体疗法使浮游菌和生物膜形成菌失活的潜力
Microorganisms. 2024 Aug 29;12(9):1795. doi: 10.3390/microorganisms12091795.
7
Variable fitness effects of bacteriophage resistance mutations in implications for phage therapy.噬菌体抗性突变的适应性影响及其对噬菌体治疗的意义。
J Virol. 2024 Oct 22;98(10):e0111324. doi: 10.1128/jvi.01113-24. Epub 2024 Aug 30.
8
Combinations of Bacteriophage Are Efficacious against Multidrug-Resistant and Enhance Sensitivity to Carbapenem Antibiotics.噬菌体组合对多药耐药菌有效,并增强对碳青霉烯类抗生素的敏感性。
Viruses. 2024 Jun 21;16(7):1000. doi: 10.3390/v16071000.
9
Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice.噬菌体疗法治疗人源化小鼠中的结核分枝杆菌感染。
Commun Biol. 2024 Mar 9;7(1):294. doi: 10.1038/s42003-024-06006-x.
10
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms.噬菌体增强抗生素治疗对耐甲氧西林金黄色葡萄球菌生物膜的协同杀菌作用。
Microbiol Spectr. 2024 Apr 2;12(4):e0321223. doi: 10.1128/spectrum.03212-23. Epub 2024 Feb 27.